Vietnam List of Narcotic Drugs Prohibited from Investment Business (Law No. 143/2025/QH15 Annex 1)

Data:47Last Updated:Mar 1, 2026
All Inventories
Vietnam List of Narcotic Drugs Prohibited from Investment Business (Law No. 143/2025/QH15 Annex 1)
Annex I of Vietnam Investment Law (Law No. 143/2025/QH15) explicitly sets forth the list of narcotic drugs prohibited from investment and business operations. This list aims to strictly fulfill obligations under international drug control conventions and prevent narcotic drugs from being invested in, produced, traded, transported, stored, used, imported or exported in Vietnam in any form. The promulgation of this list is an important measure taken by the Vietnamese government to strengthen drug control and maintain social security and public health. According to the provisions of Vietnam Investment Law, no organization or individual may invest or do business in the narcotic drugs listed in this list in any form. Violators shall bear corresponding administrative, civil or even criminal liabilities according to law. The introduction of this list further improves Vietnam drug control legal system and provides a clear legal basis for law enforcement agencies.
Update History
All
No update history
Disclaimer
1.
CIRS aims to keep the content of this site accurate and up to date. However, CIRS makes no warranties or representations regarding the quality, accuracy, completeness or reliability of information on the site.
2.
In no event shall CIRS assume or have any responsibility or liability for any information on this site or for any claims, damages or losses resulting from their use.
3.
CIRS reserves the right, at our discretion, to change, modify, add to, or remove portions of information on this site at any time without notice.
4.
CAS and CAS Registry Number are registered trademarks of the American Chemical Society. Any reference to such identifiers is made solely for the purpose of identifying chemical substances. ChemRadar is an independent platform and is not affiliated with, sponsored by, endorsed by, or an authorized partner of CAS or ACS. Based on CIRS's current review, the identifiers displayed on this platform were not obtained directly from CAS REGISTRY or any CAS subscription product or service. They were collected from governmental regulatory publications and other independent third-party sources. Users should independently verify the information before relying on it.
icon-server
message
in